$21.87 -0.20 (%) Albany Molecular Research Inc - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Benzinga's Top Initiations

    Benzinga | Sep. 9, 2014 | 09:33AM EST
  2. JP Morgan Initiates Albany Molecular Research At Overweight

    Benzinga | Sep. 9, 2014 | 07:34AM EST
  3. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD | Jul. 7, 2014 | 11:47AM EST
  4. UPDATE: Sterne Agee Reiterates On Albany Molecular Research On Raised Estimates

    Benzinga | Jul. 7, 2014 | 10:11AM EST
  5. UPDATE: Morgan Stanley Reiterates On Albany Molecular Research Ahead Of Conference Call

    Benzinga | Jun. 16, 2014 | 08:16AM EST
  6. UPDATE: Morgan Stanley Reiterates On Albany Molecular Research On Model/Valuation Update

    Benzinga | Jun. 11, 2014 | 08:49AM EST
  7. Mid-Afternoon Market Update: Markets Post a Large Rally as Intuitive Surgical Shares Remain Down

    Benzinga | Apr. 9, 2014 | 15:54PM EST
  8. Mid-Day Market Update: Alcoa Surges On Upbeat Earnings; Intuitive Surgical Shares Slip

    Benzinga | Apr. 9, 2014 | 13:06PM EST
  9. Mid-Morning Market Update: Markets Open Higher; Constellation Brands Profit Beats Street View

    Benzinga | Apr. 9, 2014 | 10:23AM EST
  10. Stocks To Watch For April 7, 2014

    Benzinga | Apr. 7, 2014 | 04:05AM EST
  11. AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc

    Benzinga | Apr. 4, 2014 | 16:06PM EST
  12. US Stock Futures Up Ahead Of Manufacturing PMI

    Benzinga | Mar. 24, 2014 | 07:24AM EST
  13. Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares Spike Higher

    Benzinga | Mar. 21, 2014 | 12:44PM EST
  14. Benzinga's Top Downgrades

    Benzinga | Dec. 3, 2013 | 08:47AM EST
  15. UPDATE: Sterne Agee Downgrades Albany Molecular Research on Less Optimism in Core Business Value

    Benzinga | Dec. 3, 2013 | 08:27AM EST
  16. AMRI Wins Development, Manufacture Contract from the UK Gov't, Provides Up to $43M in Funding

    Benzinga | Sep. 30, 2013 | 08:09AM EST
  17. AMRI Names William S. Marth as President and CEO

    Benzinga | Sep. 9, 2013 | 06:02AM EST
  18. UPDATE: Albany Molecular Research Shares Down Roughly 20% At $10.27, Fell As Much As 23.3% At Low On Disclosure That Bristol-Myers Squibb Has Canceled Development of Drug With Company

    Benzinga | Aug. 12, 2013 | 13:35PM EST
  19. Albany Molecular Files Form 8-K Disclosing Termination Of Development Of BMS-820836 With Bristol-Myers Squibb

    Benzinga | Aug. 12, 2013 | 13:15PM EST
  20. A Peek Into The Market Before The Trading Starts

    Benzinga | Feb. 11, 2013 | 01:53AM EST
  21. AMRI Announces Deal for Exclusive Rights to Tubulin Inhibitor Program for Cancer

    Benzinga | Feb. 11, 2013 | 01:08AM EST
  22. AMRI Names Saffee VP of Large Scale Manufacturing

    Benzinga | Jan. 8, 2013 | 01:11AM EST
  23. AMRI Realigns Discovery Services to Support Customer Demand

    Benzinga | Nov. 30, 2012 | 01:03AM EST
  24. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 20, 2012 | 03:24AM EST
  25. Albany Molecular Research, Inc. (AMRI) CEO Ambra Thomas E Phd D buys 10,000 Shares

    GuruFocus | Nov. 19, 2012 | 15:36PM EST
  26. Albany Molecular Research Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 9, 2012 | 07:04AM EST
  27. Albany Molecular Research Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 14:27PM EST
  28. Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN

    GuruFocus | Dec. 4, 2011 | 16:41PM EST
Trading Center